Further to an eventful 2026, Innovad Group is accelerating investment in manufacturing, biotechnology, and natural feed ingredients under the ownership of private equity firm PAI Partners, with North America and Brazil emerging as priorities for further expansion, Innovad Group CEO, Ben Letor, told Expana at EuroTier 2026 in Hanover, Germany this week.
PAI Partners completed its acquisition of Innovad Group from IK Partners in January 2026, and Letor and the management team reinvested alongside the new owner. The deal ended IK’s ownership, which began in 2021. During that period, Innovad Group achieved double-digit revenue growth, expanded into primary ingredients, strengthened its phytogenic portfolio and completed three acquisitions.
“It’s exciting to work with investment firms. They give you a new tempo and there’s an obligation of results via transformation, so it’s a dynamic environment and the ambition level has changed,” Letor said. “It’s very much a buy and build strategy and investing for the future. We have a stronger base and we are scaling up with speed. The vision is to be an alternative solutions offering provider focused on our three platforms.”
Those platforms are biomonitoring, phytogenics and biotechnology. Biomonitoring focuses on diagnostic tools to identify and assess mycotoxin exposure and its effects on animal health. Phytogenics covers plant-derived ingredients supporting animal health, gut function and performance, principally through its Herbonis business. Biotechnology encompasses biological solutions, including probiotics and technologies.
“Our three platforms are where we want to invest,” Letor said. “We’re gaining traction with the three,” he added.
Additional production capacity and manufacturing investment are part of the group’s expansion plans. In Belgium, Innovad Group has completed the rebuilding of its Essen site, doubling the output of its packaging lines and adding office space. The facilities opened in June 2026.
“When you invest in a plant that needs to continue functioning, that is costly,” Letor said, adding that further capital expenditure is on the agenda to adjust and expand factory operations in Brazil. “If we have the chance to acquire a new technology platform to complement our existing offering or some additional manufacturing expertise, then why not,” he stated.
In Europe, Innovad Group announced a majority-owned joint venture with Greek company Olea Fortius in October 2026, bringing together olive oil coproduct expertise and the scientific capabilities of FoodOxys, a University of Thessaly spin-off. The partnership will develop standardized olive pulp and essential oils from Greek aromatic plants, with oregano oil identified as an initial project.
The collaboration builds on Innovad Group’s existing work on olive-derived ingredients. The company is also introducing a new olive-based solution at EuroTier. For Letor, the Olea Fortius partnership reflects Innovad Group’s ambition to strengthen its phytogenic platform through pioneering ingredients and additional scientific expertise.
But North America is a major priority for the next phase of expansion. Innovad Group intends to deploy more capital in the region, either through an acquisition or by expanding its manufacturing footprint. The US dairy industry is a particular focus.
The US is seen to be a potential third regional hub alongside the group’s established European and Brazilian operations, Letor said.
Brazil has also become an increasingly important growth engine. In August 2026, Innovad Group announced an agreement to acquire Brazilian biotechnology company Cinergis through its subsidiary Oligo Basics. Completed at the end of September, the acquisition added local technology, probiotic solutions targeting Salmonella, and manufacturing facilities in Jaguariúna and Paulínia. Innovad Group is currently integrating Cinergis’ 66 employees.
The acquisition is intended to accelerate manufacturing capabilities, increase local production, create cross-selling opportunities, and make Brazil a platform for expansion across Latin America.
Written by Simon Duke